Allogeneic Hematopoietic Stem Cell Transplantation
📧 Sign up to get email alerts when something new happens for Allogeneic Hematopoietic Stem Cell Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT [Phase 2, Phase 3]
Clinical trial update comparing G-CSF+DAC+BUCY versus G-CSF+DAC+BF conditioning regimens for high-risk myelodysplastic syndrome patients und…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT [Phase 2, Phase 3]
A trial update comparing G-CSF+DAC+BUCY versus G-CSF+DAC+BF conditioning regimens for patients with secondary acute myeloid leukemia evolvin…
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT [Phase 2, Phase 3]
Clinical trial comparing G-CSF plus Decitabine with BU-CY conditioning versus BU-CY alone for RAEB-1/RAEB-2 and AML secondary to MDS in allo…
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating escalation antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT [Phase 2, Phase 3]
A Phase 2/Phase 3 trial compares G-CSF+DAC+BUCY versus G-CSF+DAC+BF conditioning regimens for RAEB-1/REAB-2 and AML secondary to MDS in pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT [Phase 2, Phase 3]
Phase 2/3 clinical trial update on a Dec+Flu+Bu conditioning regimen for elderly AML patients undergoing allogeneic hematopoietic stem cell …
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT [Phase 2, Phase 3]
Phase 2/3 trial evaluating decitabine in combination with a BUCY conditioning regimen versus BUCY alone for TP53+ myeloid tumors undergoing …
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT [Phase 1]
Phase 1 dose-finding study of vedolizumab for graft-versus-host disease in participants undergoing allogeneic hematopoietic stem cell transp…
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating antibacterial prophylaxis versus no prophylaxis in hematological malignancy patients prior to allogene…
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)
A completed prospective cohort study evaluating biomarkers after allogeneic hematopoietic stem cell transplantation (HCT).